[脊髓质瘤的多模式治疗:最新]
Toshiki Endo1, Yoshiharu Takahashi, Taketo Nishizawa
1Division of Neurosurgery, Tohoku Medical and Pharmaceutical University.
No shinkei geka. Neurological surgery
|January 30, 2025
概括
本综述涵盖了脊柱恶性质瘤的诊断标准和治疗方法,包括IDH野生型质母细胞瘤和H3-K27改变的扩散中线质瘤. 目前的治疗方法显示预后不好,但新的治疗方法提供了希望.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 瘤外科手术是一项瘤外科手术.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...